Scantox Ballerup ApS: Financial statements 2015
CVR: 34724938
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Scantox Ballerup ApS (CVR 34724938) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 8,691,905 and a net result of DKK 3,564,681 compared with DKK 89,675 the year before. That is an increase of 21.4% compared with the year before. Equity in the 2015 report amounted to DKK 2,249,558. The solvency ratio was 9.9%.
- Gross Profit
- DKK 8,691,905
- Profit/Loss
- DKK 3,564,681
- Equity
- DKK 2,249,558
- Total Assets
- DKK 22,789,297
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 8.7 mio. | 3.6 mio. | 2.2 mio. | - |
| 2014 | - | 7.2 mio. | 90 t. | 215 t. | - |
Official annual report
How creditworthy is Scantox Ballerup ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
Scantox Ballerup ApS has published its annual report for 2014. Gross profit came to DKK 7,158,131, and the net result was DKK 89,675.
About Scantox Ballerup ApS
Scantox Ballerup ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SOLURAL PHARMA ApS. The management consists of Helle Kirstein Erichsen. The board consists of Jeanet Løgsted Nielsen (chair) and Emil Staal Bergander. The company is owned by Scantox Denmark ApS. The company has 14 employees (2026). In 2025, the company reported a gross profit of DKK 13,349,106 and a net result of DKK -1,931,049 compared with DKK 255,010 the year before. Equity in the 2025 report amounted to DKK -1,539,321.